Locomizer steams ahead with $300,000

Locomizer, a UK-based adtech developer based on research conducted at the National Institute for Medical Research, has obtained $300,000 in seed capital from Impulse VC and Phystech Ventures, East-West Digital News reported today.

Locomizer is developing a user profiling technology called AffinityBI, which the company describes as a fusion of biology and technology. The initial research was conducted by co-founder Alexei Poliakov at the National Institute for Medical Research.

The round, which may be extended to up to $1.5m by the end of 2016, will support the international expansion of the company.

In 2013, the company received £100,000 ($144,000) from incubator Collider12.

Kirill Belove, managing partner at Impulse VC, said: “Locomizer is a good example of how the real world is being digitised and converted into big data, to create value-added products and services for their customers and end-users. This is just one of a few projects that bring a real ‘tech’ meaning to adtech.”